Novo Nordisk A/S Depositary Receipt (NVON)
Market Closed
10 Aug, 20:00
NEO-L NEO-L Primary CA$
4. 99
+0.03
+0.6048%
CA$
20.66B Market Cap
48.26 P/E Ratio
0.32% Div Yield
36,946 Volume
0 Eps
CA$ 4.96
Previous Close Want to track NVON and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novo Nordisk A/S Depositary Receipt (NVON) Statistics
Valuation metrics
Market Cap 20.66B
Enterprise value 31.11B
Trailing P/E (ttm) 0.79
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.06
Price/Book (mrq) 0.48
Enterprise Value/Revenue 0.44
Enterprise Value/EBITDA 0.84
Overview
Shares outstanding 4.44B
Float 3.19B
Shares short 647
% Held by insiders -
% Held by institutions -
Average volume (10 days) 63.12K
Average volume (90 days) 52.07K
Price summary
52-Week low 3.7
52-Week high 6.63
Beta 0.35
50-Day moving average 4.16
200-Day moving average 5.14
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.37%
Operating margin 0.62%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.71%
Income Statement
Revenue (ttm) 70.12B
Revenue per share (ttm) 73.77
Quarterly revenue growth (yoy) 0.24%
Gross profit (ttm) 58.33B
EBITDA 181.54B
Net income to common (ttm) 26.09B
Diluted EPS (ttm) 5.89
Quarterly earnings growth (yoy) 0.67%
Balance Sheet
Total cash (mrq) 4.63B
Total cash per share (mrq) 4.87
Total debt (mrq) 31.31B
Total Debt/Equity (mrq) 72.09
Current ratio (mrq) 0.79%
Book value per share (mrq) 9.79
Cash Flow
Cash flow statement 25.34B
Levered free cash flow (LFCF) -2.58B
